Rothia mucilaginosa bacteremia after pneumonia in patient with cirrhosis: First report from Vietnam

Pham Dang Hai^{1

2}, Le Thi Viet Hoa^{3

2}

Affiliations

Pham Dang Hai et al. New Microbes New Infect. 2022.

. 2022 May 13:47:100984.

doi: 10.1016/j.nmni.2022.100984. eCollection 2022 Apr-May.

Pham Dang Hai^{1

2}, Le Thi Viet Hoa^{3

2}

No abstract available

Keywords: Bacteremia; Rothia mucilaginosa; Vietnam; cirrhosis; emerging pathogen.

References

1. Getzenberg R.B., Hijano D.R., Hakim H., Dallas R.H., Ferrolino J.A., Brazelton De Cardenas J., et al. Rothia mucilaginosa infections in pediatric cancer patients. J Pediatr Infect Dis Soc. 2021;10:341–344. doi: 10.1093/jpids/piaa047. - DOI - PMC - PubMed
1. McWhinney P.H.M., Kibbler C.C., Gillespie S.H., Patel S., Morrison D., Hoffbrand A.V., et al. Stomatococcus mucilaginosus: an emerging pathogen in neutropenic patients. Clin Infect Dis. 1992;14:641–646. doi: 10.1093/clinids/14.3.641. - DOI - PubMed
1. Bayhan C., Öncel E.K., Cengiz A.B., Öksüz A.B., Aydin G.B. Bacteremia caused by Rothia mucilaginosa after pneumonia, in a patient with hematopoietic stem cell transplantation. Arch Argent Pediatr. 2016;114:e343–e345. doi: 10.5546/aap.2016.e343. - DOI - PubMed
1. Ramanan P., Barreto J.N., Osmon D.R., Tosh P.K. Rothia bacteremia: A 10-year experience at Mayo Clinic, Rochester, Minnesota. J Clin Microbiol. 2014;52:3184–3189. doi: 10.1128/JCM.01270-14. - DOI - PMC - PubMed
1. Von Eiff C., Herrmann M., Peters G. Antimicrobial susceptibilities of Stomatococcus mucilaginosus and of Micrococcus spp. Antimicrob Agents Chemother. 1995;39:268–270. doi: 10.1128/aac.39.1.268. - DOI - PMC - PubMed